日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer evolution and multi-omic profile of relapsed colorectal liver metastases after treatment

治疗后复发性结直肠肝转移的癌症演变和多组学特征

Tomás, Laura; Raschzok, Nathanael; Blanc, Eric; Gallardo-Gómez, María; Menne, Andrea; Astrahantseff, Kathy; De Chiara, Loretta; Geisel, Dominik; Pratschke, Johann; Modest, Dominik P; Eggert, Angelika; Beule, Dieter; Posada, David; Sers, Christine; Mamlouk, Soulafa

Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy

结直肠癌肝转移的蛋白质组学分析揭示了化疗疗效的组织病理学反应特异性分子特征。

Böhm, Agnes K; Skrip, Lisa M; Klein, Oliver; Strobl, Felix; Wieland, Jonas K; Arnold, Alexander; Zhou, Yijun; Papke, Björn; Sers, Christine; Modest, Dominik P; Moosburner, Simon; Haber, Philipp K; Krenzien, Felix; Raschzok, Nathanael; Schöning, Wenzel; Horst, David; Malinka, Thomas; Sack, Ingolf; Pratschke, Johann; Sauer, Igor M; Hillebrandt, Karl H

PROTECTOR / FIRE‑10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancer

PROTECTOR / FIRE-10:一项前瞻性、随机、开放标签、多中心 III 期临床试验的研究方案,旨在研究术前全身治疗对晚期结肠癌的疗效

Siegel, Robert; Dittrich, Luca; Plewe, Julius; Denecke, Timm; Leonhardi, Jakob; Tannapfel, Andrea; Reinacher-Schick, Anke; Raschzok, Nathanael; Sauer, Igor Maximilian; Lauscher, Johannes; Lorenzen, Sylvie; Götze, Thorsten; Jelas, Ivan; Stahler, Arndt; Kurreck, Annika; Ballhausen, Alexej; Ostendorf, Benjamin Nils; Haase, Oliver; Pratschke, Johann; Stintzing, Sebastian; Modest, Dominik Paul

Post-COVID-19 Rabies Surveillance and Risk Factors in Rural Eastern Cape, South Africa: A One Health Perspective

南非东开普省农村地区新冠疫情后狂犬病监测及风险因素:一体化健康视角

Moso, Sithabile; Gonah, Laston; Hosu, Mojisola Clara; Dlatu, Ntandazo; Apalata, Teke; Faye, Lindiwe Modest

Ongoing Worry, Information Needs, and Engagement in Care for Parents of Long-Term Childhood Cancer Survivors

长期儿童癌症幸存者父母的持续担忧、信息需求和参与照护情况

Crisler, Katia M; McCormick, Katherine G; Modest, Anna M; Recklitis, Christopher J; Greenzang, Katie A

Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative review

将肝移植作为不可切除结直肠癌肝转移瘤的治疗选择成功应用于临床常规的必要条件——叙述性综述

Walter, Kilian Alexander; Moosburner, Simon; Kreutz, Tabea; Gassner, Joseph Mgv; Öllinger, Robert; Krenzien, Felix; Modest, Dominik Paul; Guba, Markus; Pascher, Andreas; Pratschke, Johann; Raschzok, Nathanael

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)

接受特殊姑息治疗的晚期癌症患者的心力衰竭治疗(EMPATICC 试验)

Anker, Markus S; Mahabadi, Amir A; Totzeck, Matthias; Tewes, Mitra; Khan, Muhammad Shahzeb; Mincu, Raluca I; Hendgen-Cotta, Ulrike B; Michel, Lars; Mathew, Baicy; Drescher, Ophelia; Schuler, Martin; Keller, Ulrich; Rieger, Kathrin; Ahn, Johann; Bullinger, Lars; Modest, Dominik P; Denecke, Corinna; Kretzler, Lucie; Ramer, Luisa V; Krug, Danara; Landmesser, Ulf; Lehmann, Lorenz H; Frey, Norbert; Bercker, Sven; Laufs, Ulrich; Böhm, Michael; Mahfoud, Felix; Merkely, Bela; Diek, Monika; Butler, Javed; Veiser, Anja; Heise, Tim; Hellmich, Martin; Placzek, Marius; Friede, Tim; Anker, Stefan D; Rassaf, Tienush

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer

索托拉西布联合帕尼单抗与研究者选择的方案治疗化疗难治性KRAS G12C突变型结直肠癌的III期CodeBreakK 300研究的总生存期分析

Pietrantonio, Filippo; Salvatore, Lisa; Esaki, Taito; Modest, Dominik Paul; Lopez-Bravo, David Paez; Taieb, Julien; Karamouzis, Michalis V; Ruiz-Garcia, Erika; Kim, Tae Won; Kuboki, Yasutoshi; Meriggi, Fausto; Cunningham, David; Yeh, Kun-Huei; Chan, Emily; Chao, Joseph; Tran, Qui; Cremolini, Chiara; Fakih, Marwan

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials

人表皮生长因子受体2在接受化疗联合贝伐单抗或抗EGFR治疗的转移性结直肠癌患者中的影响:八项随机试验的探索性分析

Germani, Marco Maria; Borelli, Beatrice; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Oldani, Simone; Battaglin, Francesca; Bergamo, Francesca; Salvatore, Lisa; Stahler, Arndt; Antoniotti, Carlotta; Shitara, Kohei; Venook, Alan; Oki, Eiji; Muro, Kei; Ugolini, Clara; Soeda, Junpei; Lonardi, Sara; Pietrantonio, Filippo; Lenz, Heinz-Josef; Modest, Dominik Paul; Yoshino, Takayuki; Cremolini, Chiara

Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial

帕尼单抗联合 5-氟尿嘧啶和亚叶酸钙或单独使用 5-氟尿嘧啶和亚叶酸钙作为 RAS 野生型转移性结直肠癌的维持治疗(PanaMa,AIO KRK 0212):一项随机、开放标签、II 期试验的最终疗效分析

Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H S; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P